Esperion Therapeutics
ESPR
ESPR
142 hedge funds and large institutions have $598M invested in Esperion Therapeutics in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 42 increasing their positions, 45 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
26% less capital invested
Capital invested by funds: $805M → $598M (-$206M)
30% less call options, than puts
Call options by funds: $14.9M | Put options by funds: $21.3M
42% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 31
Holders
142
Holding in Top 10
1
Calls
$14.9M
Puts
$21.3M
Top Buyers
| 1 | +$11.2M | |
| 2 | +$8.46M | |
| 3 | +$5.9M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$3.01M |
| 5 |
MG
Meditor Group
Hamilton,
Bermuda
|
+$2.94M |
Top Sellers
| 1 | -$18.2M | |
| 2 | -$10.5M | |
| 3 | -$7.43M | |
| 4 |
PCM
Pentwater Capital Management
Naples,
Florida
|
-$6.73M |
| 5 |
Axa
Paris,
France
|
-$3.57M |